• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

sCD22 Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS695571

Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hCD22. Anti-Human CD22 specific antibody was purified by affinity chromatography employing immobilized hCD22 matrix. More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Product Name
sCD22, Polyclonal Antibody
Full Product Name
Anti-human sCD22
Product Gene Name
anti-sCD22 antibody
Product Synonym Names
Anti-Human sCD22
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human
Form/Format
Purified
Preparation and Storage
At -20 degree C
Molecular Weight
75,354 Da
OMIM
107266
3D Structure
ModBase 3D Structure for P20273
Immunogen
Recombinant Human sCD22
Applications Tested/Suitable for anti-sCD22 antibody
ELISA (EIA), Western Blot (WB)
Application Notes for anti-sCD22 antibody
Sandwich ELISA: To detect hCD22 by sandwich ELISA (using 100 mul/well antibody solution) a concentration of 0.5 - 2.0 mug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human CD22 as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hCD22.

Western Blot: To detect hCD22 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hCD22 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Other Notes

Small volumes of anti-sCD22 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for sCD22 purchase

MBS695571 is an antibody targeting sCD22. Also known as Anti-human sCD22. Reactive in Human. Host: Rabbit.

Additional Details

NCBI/Uniprot data below describe general gene information for sCD22. It may not necessarily be applicable to this product.

NCBI GI #
6166019
NCBI GeneID
933
NCBI Accession #
P20273.2
UniProt Primary Accession #
P20273
UniProt Secondary Accession #
O95699; O95701; O95702; O95703; Q01665; Q32M46; Q92872; Q92873; Q9UQA6; F5GYU4; F5H7U3
UniProt Related Accession #
P20273
NCBI Official Full Name
B-cell receptor CD22
NCBI Official Synonym Full Names
CD22 molecule
NCBI Official Symbol
CD22
NCBI Official Synonym Symbols
SIGLEC2; SIGLEC-2
UniProt Protein Name
B-cell receptor CD22
UniProt Synonym Protein Names
B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD_antigen: CD22
UniProt Gene Name
CD22
UniProt Synonym Gene Names
SIGLEC2; BL-CAM; Siglec-2
UniProt Entry Name
CD22_HUMAN
NCBI Protein Information
B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2

UniProt Comments for sCD22

CD22: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. Belongs to the immunoglobulin superfamily. SIGLEC (sialic acid binding Ig-like lectin) family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Membrane protein, integral; Cell surface

Chromosomal Location of Human Ortholog: 19q13.1

Cellular Component: integral to plasma membrane; external side of plasma membrane

Molecular Function: protein binding; carbohydrate binding

Biological Process: cell adhesion
Show more

Research Articles on sCD22

1. study detected the expression of CD22 and CD72 on B cells of myasthenia gravis, compared to multiple sclerosis patient controls and healthy controls y

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Pathways associated with anti-sCD22 antibody

 Products by Pathway  Pathway Diagram
 B Cell Receptor Signaling Pathway antibodies  B Cell Receptor Signaling Pathway Diagram
 B Cell Receptor Signaling Pathway antibodies  B Cell Receptor Signaling Pathway Diagram
 B Cell Receptor Signaling Pathway antibodies  B Cell Receptor Signaling Pathway Diagram
 BCR Signaling Pathway antibodies  BCR Signaling Pathway Diagram
 Cell Adhesion Molecules (CAMs) Pathway antibodies  Cell Adhesion Molecules (CAMs) Pathway Diagram
 Cell Adhesion Molecules (CAMs) Pathway antibodies  Cell Adhesion Molecules (CAMs) Pathway Diagram
 Hematopoietic Cell Lineage Pathway antibodies  Hematopoietic Cell Lineage Pathway Diagram
 Hematopoietic Cell Lineage Pathway antibodies  Hematopoietic Cell Lineage Pathway Diagram

Diseases associated with anti-sCD22 antibody

 Disease Name  Pubmed Publications
 Immune System Diseases Antibodies  >952 publications with sCD22 and Immune System Diseases
 Neoplasms, Experimental Antibodies  >105 publications with sCD22 and Neoplasms, Experimental
 Death Antibodies  >62 publications with sCD22 and Death
 Inflammation Antibodies  >56 publications with sCD22 and Inflammation
 Necrosis Antibodies  >51 publications with sCD22 and Necrosis
 Respiratory Tract Diseases Antibodies  >45 publications with sCD22 and Respiratory Tract Diseases
 Cell Transformation, Neoplastic Antibodies  >23 publications with sCD22 and Cell Transformation, Neoplastic
 Kidney Diseases Antibodies  >21 publications with sCD22 and Kidney Diseases
 Liver Diseases Antibodies  >19 publications with sCD22 and Liver Diseases
 Lung Diseases Antibodies  >17 publications with sCD22 and Lung Diseases

Organs/Tissues associated with anti-sCD22 antibody

 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >1048 publications with sCD22 and Blood
 Bone Marrow Antibodies  >286 publications with sCD22 and Bone Marrow
 Spleen Antibodies  >121 publications with sCD22 and Spleen
 Lymph Node Antibodies  >110 publications with sCD22 and Lymph Node
 Lymph Antibodies  >100 publications with sCD22 and Lymph
 Skin Antibodies  >47 publications with sCD22 and Skin
 Lung Antibodies  >32 publications with sCD22 and Lung
 Thymus Antibodies  >31 publications with sCD22 and Thymus
 Tonsil Antibodies  >31 publications with sCD22 and Tonsil
 Kidney Antibodies  >31 publications with sCD22 and Kidney
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000